Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1600
-0.0050 (-3.03%)
Apr 20, 2026, 3:58 PM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 79.53 million as of April 20, 2026. Its market cap has increased by 192.84% in one year.
Market Cap
79.53M
Enterprise Value
50.75M
Revenue
5.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 79.53M, an increase of 130.54%. That is a compound annual growth rate of 7.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 84.66M | 10.00% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Botanix Pharmaceuticals | 97.57M |
| Cynata Therapeutics | 85.48M |
| LTR Pharma | 72.71M |